Literature DB >> 9000102

Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

M Mendelson1, S Monard, P Sissons, J Sinclair.   

Abstract

The cellular sites and mechanisms of human cytomegalovirus (HCMV) latency are still poorly defined. Although evidence suggests that peripheral blood monocytes are one site of latency in the healthy carrier, it is unlikely that monocytes represent a site of primary HCMV infection. Consequently, we have analysed CD34+ bone marrow progenitors, precursors of monocytes, to determine whether they are a site of HCMV carriage in normal virus carriers. For the first time, we demonstrate the presence of endogenous HCMV within bone marrow progenitors in the absence of HCMV lytic gene expression. These findings are consistent with previous evidence showing that the permissiveness of myeloid cells for HCMV is critically dependent on the differentiation state of the cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9000102     DOI: 10.1099/0022-1317-77-12-3099

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  160 in total

1.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Quantitative analysis of latent human cytomegalovirus.

Authors:  B Slobedman; E S Mocarski
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection.

Authors:  K L White; B Slobedman; E S Mocarski
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Authors:  Laura Hertel; Vashti G Lacaille; Herbert Strobl; Elizabeth D Mellins; Edward S Mocarski
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.

Authors:  Xiaoqiu Liu; Jinxiang Yuan; Allen W Wu; Patrick W McGonagill; Courtney S Galle; Jeffery L Meier
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

7.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

8.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants.

Authors:  Johannes Meier; Uta Lienicke; Edda Tschirch; Detlev H Krüger; Roland R Wauer; Susanna Prösch
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.